{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 16, "transaction_limit": 160, "filters": {"q": "", "ticker": "APRE", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 16, "acquisition_count": 16, "disposal_count": 0, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 0.0, "disposal_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "flow_tone": "positive", "largest_value_label": "$0", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 16, "value": "0.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$0"}], "days": [{"transaction_date": "2026-06-16", "acquisitions": 16, "disposals": 0, "total": 16, "bar_width": 100.0}], "side_mix": {"acquisitions": 16, "disposals": 0, "acquisition_share": 100.0, "disposal_share": 0.0}}, "company_flows": [{"symbol": "APRE", "name": "Aprea Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-16", "acquisitions": 16, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}], "company_overview": [{"symbol": "APRE", "name": "Aprea Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-16", "filings": 16, "acquisitions": 16, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}], "transactions": [{"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "BIZZARI, JEAN-PIERRE", "executive_title": "Director", "security_type": "Stock Options (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 12555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.860271+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "BIZZARI, JEAN-PIERRE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3135.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.858700+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "DUEY, MARC", "executive_title": "Director", "security_type": "Stock Options (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 12555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.863483+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "DUEY, MARC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3135.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.862016+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "GRISSINGER, MICHAEL", "executive_title": "Director", "security_type": "Stock Options (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 12555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.846167+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "GRISSINGER, MICHAEL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3135.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.842966+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "GRUIA, GABRIELA", "executive_title": "Director", "security_type": "Stock Options (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 12555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.849936+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "GRUIA, GABRIELA", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3135.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.848134+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "HENNEMAN, JOHN B III", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3135.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.855166+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "HENNEMAN, JOHN B III", "executive_title": "Director", "security_type": "Stock Options (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 12555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.856897+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "PAMUKCU, RIFAT", "executive_title": "Director", "security_type": "Stock Options (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 12555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.866519+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "PAMUKCU, RIFAT", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3135.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.864969+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "PETERS, RICHARD", "executive_title": "Director", "security_type": "Stock Options (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 12555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.853509+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "PETERS, RICHARD", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3135.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.851698+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "SEIZINGER, BERND R.", "executive_title": "Director", "security_type": "Stock Options (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 12555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.836843+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}, {"symbol": "APRE", "name": "Aprea Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "SEIZINGER, BERND R.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3135.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:09:08.868275+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/apre/", "research_links": {"chart": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/", "report": "/terminal/02d230d0-066f-4cd9-843e-312ad1a517d6/report/", "factor": "/factors/ticker/02d230d0-066f-4cd9-843e-312ad1a517d6/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}